ReVance, topical botox company, raises $8M more
ReVance Therapeutics, a Mountain View, Calif biopharma company focused on topical botox, has raised $8 million more in financing.
Backers include executives of the company, Niagra Gorge Venture Partners, Biotechnology Development Fund, Essex Woodlands Health Ventures, Technology Partners Fund and Medics Pharma Corp.
It is the second portion of the company’s third round. Just last year, it raised $43 million.
Next Story: Online cooking marketplace Cooking.com stirs up $7.1M
Previous Story: Arrival of the phone backup services: FusionOne, Dashwire, Backup-Pal
About the Author, Matt Marshall
Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.